Pine Injection 1,000 IU/mL (Heparin Sodium)
Heparin Sodium
Prescription medication
Huons Co., Ltd.
MFDS item code 199903185 · Notified 1999.07.05 · Insurance code 670602341,670607571
Prevention and treatment of thrombosis and embolism; diagnosis and treatment of coagulation disorders; inhibition of blood coagulation
This medication is used to prevent thrombosis and to prevent and treat postoperative thrombosis and pulmonary embolism. It also helps in the prevention and treatment of embolic atrial fibrillation, and is used in the diagnosis and treatment of acute and chronic coagulopathy. It prevents blood coagulation during vascular and cardiac surgeries and is effective in preventing cerebral thrombosis due to cerebral hemorrhage. Additionally, it is used to prevent coagulation during transfusions, extracorporeal circulation, and dialysis, as well as in the treatment of coronary artery occlusion and peripheral vascular embolism. Overall, it plays an important role in preventing and treating various thrombotic disorders by regulating blood coagulation.
Usually administered by intravenous injection or added to the perfusion blood during extracorporeal circulation. The effect occurs immediately after administration. However, heparin sensitivity varies greatly among individuals, so perform a heparin sensitivity test before administration and measure blood coagulation time afterward to determine the maintenance dose. After use, blood coagulation time is usually maintained at 15 ~ 20 minutes or longer, but the dose is determined according to the individual case, indication, and purpose. 1. Extracorporeal circulation 1) Artificial kidney (1) Systemic heparinization method: Administer 1,000 ~ 5,000 IU of heparin sodium before starting dialysis. After dialysis begins, administer an additional 500 ~ 1,500 IU per hour continuously or intermittently every hour. (2) Regional heparinization method: Administer this drug continuously at 1,500 ~ 2,500 IU per hour and neutralize it with protamine sulfate during perfusion in the body. 2) Blood perfusion using a heart-lung machine : Administer 150 ~ 300 IU of this drug per kg of body weight and, as the extracorporeal circulation time is extended, add an appropriate amount as needed. After extracorporeal circulation, use protamine sulfate to prevent postoperative bleeding and neutralize the heparin effect. 2. Intravenous infusion Dissolve 10,000 ~ 30,000 IU of this drug in 1,000 mL of 5 % dextrose injection, normal saline injection, or Ringer's solution, and infuse at a rate of approximately 30 drops per minute. When whole blood clotting time reaches 2 ~ 3 times the pre-administration value, infuse at a rate of approximately 20 drops per minute. 3. Intermittent intravenous injection Administer 5,000 ~ 10,000 IU of this drug intravenously every 4 ~ 8 hours. Beginning 3 hours after initiation of administration, measure whole blood clotting time every 2 ~ 4 hours and adjust the dose so that it reaches 2 ~ 3 times the pre-administration value. 4. Subcutaneous injection Inject 10,000 ~ 20,000 IU of this drug subcutaneously, followed by a maintenance dose of 15,000 ~ 20,000 IU every 12 hours. Use a different injection site each time to prevent hematoma formation. 5. Blood transfusion and blood testing For blood transfusion, usually use 400 ~ 500 IU of this drug per 100 mL of blood; for blood testing, use 100 IU per 20 ~ 30 mL of blood.
This medication is a very potent drug and should only be used under the strict supervision of a physician. Special caution should be exercised when used in patients with diseases that have a high risk of bleeding, as various areas of bleeding may occur in patients receiving this medication. Benzyl alcohol contained in this medication can cause serious respiratory issues in premature or low-birth-weight infants, so caution is advised. It should not be administered to patients who have an allergy to this medication or its components, those with inappropriate blood coagulation test results, patients with a tendency to bleed, or patients with severe liver or kidney dysfunction. Patients who have undergone central nervous system or eye surgery recently, those who have received spinal or epidural anesthesia, patients with specific histories of thrombocytopenia, and neonates should also not receive this medication. Careful administration is required in patients with consumptive coagulopathy, catheterization, late-term pregnant women, those with lens hemorrhage or severe retinal lesions, patients with liver or kidney dysfunction, children, and the elderly. Monitor coagulation state frequently and carefully observe for signs of bleeding. This medication may cause side effects such as bleeding, thrombocytopenia, liver dysfunction, hypersensitivity reactions, skin issues, osteoporosis or renal suppression with long-term use. Local pain or hematoma may occur at the injection site and rarely, thrombosis or severe allergic reactions may occur; if adverse symptoms appear, contact medical personnel immediately. While using this medication, regularly verify blood coagulation test results, and if bleeding becomes severe or there is a rapid decrease in platelet count, discontinue administration. Moreover, sudden cessation of the anticoagulant effect of this medication can pose a risk of thrombosis, so dosage should be gradually reduced. Due to potential interactions with other medications taken concurrently, the risk of bleeding may increase or efficacy may change; it is essential to inform medical personnel of any medications being taken. Women who are pregnant or breastfeeding should use caution due to the risk of uterine and placental hemorrhage; while this medication is not secreted in breast milk, caution is necessary due to the presence of benzyl alcohol. Special care is needed for children and the elderly as they may have an increased risk of bleeding. Overdosage can result in hemorrhagic complications, so immediate treatment is required, and protamine sulfate may be used as an antidote, but it also carries risks of side effects, so caution is warranted. While under treatment, avoid intramuscular injections, and do not mix this medication with antihistamines for injection.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not allow light to pass through. Also, it is best to store it at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.
A clear solution that is colorless to pale yellow contained in a brown vial.
5 mL/vial x 10, 20 mL/vial x 10
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Heparin Sodium
Prescription medication
Huons Co., Ltd.
Heparin Sodium
Injections · Prescription medication
JW Pharmaceutical Corporation
Heparin Sodium
Prescription medication
Hallym Pharmaceutical Co., Ltd.
Heparin Sodium
Injections · Prescription medication
JW Pharmaceutical Co., Ltd.
Heparin Sodium
Prescription medication
Huons Co., Ltd.
Heparin Sodium
Injections · Prescription medication
Green Cross Corporation
Heparin Sodium
Prescription medication
Hyun's Co., Ltd.
Heparin Sodium
Prescription medication
BM Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.